ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
Public ClinicalTrials.gov record NCT06828861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients With Prader-Willi Syndrome
Study identification
- NCT ID
- NCT06828861
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Aardvark Therapeutics, Inc.
- Industry
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- ARD-101 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 7 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2024
- Primary completion
- Feb 28, 2027
- Completion
- Mar 31, 2027
- Last update posted
- Apr 8, 2026
2024 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's of Alabama | Birmingham | Alabama | 35233-1711 | — |
| Rady Children's Hospital | Encinitas | California | 92123 | — |
| Children's Hospital of Orange Country | Orange | California | 92868 | — |
| Stanford Children's Health Specialty Services | Palo Alto | California | 94304 | — |
| Children's Hospital Colorado | Denver | Colorado | 80045-7106 | — |
| Nemours Children Clinic Wilmington | Wilmington | Delaware | 19803-3607 | — |
| UF Shands Children's Hospital | Gainesville | Florida | 32610-3008 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322-1047 | — |
| Ann and Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611-2991 | — |
| The Johns Hopkins Hospital | Baltimore | Maryland | 21287-0005 | — |
| University of Minnesota Masonic Children's Hospital | Minneapolis | Minnesota | 55102 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219-2918 | — |
| NYU Langone Children's Ambulatory Care Center | Mineola | New York | 11501-4077 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-0005 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06828861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06828861 live on ClinicalTrials.gov.